Monitoring and controlling drug precursors
In interinstitutional negotiations (trilogues). Parliament and Council are working toward a provisional agreement, which would still need formal adoption to become law.
Last active 13 Nov 2026
AI system. Responses may contain errors. Why this matters
What this bill does
In plain terms: what it changes and who it affects.
This proposal tightens EU controls on chemicals used to make illegal drugs while simplifying lawful trade through one digital system.
It affects chemical manufacturers, distributors, importers, exporters, online marketplaces, research organisations, pharmacies, veterinary dispensaries, and industries using precursor chemicals, especially SMEs.
- Merges internal-market and external-trade precursor rules into one directly applicable regulation.
- Creates a new banned category for designer precursors, with limited research and innovation exceptions.
- Replaces several paper or authorisation processes with a central electronic system and customs interconnection.
- Strengthens reporting, seizure, customs-control, training, and online marketplace obligations for suspicious precursor activity.
- Takes effect
- It enters into force 20 days after Official Journal publication and generally applies three years after entry into force.
- Transitional law
- Existing licences and registrations remain valid until expiry or four years after entry into force, whichever comes first.
- Regulation (EC) No 273/2004 (32004R0273)
- entire act: repeals the entire regulation
- Regulation (EC) No 111/2005 (32005R0111)
- entire act: repeals the entire regulation
Latest update
13 Nov 2026The most recent development in this bill's progress.
Trilogues (interinstitutional negotiations) → Trilogues (interinstitutional negotiations)
Trilogues (interinstitutional negotiations) → Trilogues (interinstitutional negotiations)
Documents
1 recentSourcesOEILEUR-LexEU Law Tracker